Back to Search Start Over

Synergistic bactericidal effect of antimicrobial peptides and copper sulfide-loaded zeolitic imidazolate framework-8 nanoparticles with photothermal therapy.

Authors :
Zhang, Duoduo
Bie, Shiyue
Anas Tomeh, Mhd
Zhang, Xinyu
Zhao, Xiubo
Source :
European Journal of Pharmaceutics & Biopharmaceutics. Nov2024, Vol. 204, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

[Display omitted] Antimicrobial resistance (AMR) has emerged as a significant threat to human health. Antimicrobial peptides (AMPs) have proven to be an effective strategy against antibiotic-resistant bacteria, given their capacity to swiftly disrupt microorganism membranes and alter cell morphology. A common limitation, however, lies in the inherent toxicity of many AMPs and their vulnerability to protease degradation within the body. Photothermal therapy (PTT) stands out as a widely utilized approach in combating antibiotic-resistant bacterial infections, boasting high efficiency and non-invasive benefits. To enhance the stability and antibacterial efficacy of AMPs, a novel approach involving the combination of AMPs and PTT has been proposed. This study focuses on the encapsulation of At10 (an AMP designed by our group), and copper sulfide nanoparticles (CuS NPs) within zeolitic imidazolate framework-8 (ZIF-8) to form nanocomposites (At10/CuS@ZIF-8). The encapsulated CuS NPs exhibit notable photothermal properties upon exposure to near-infrared radiation. This induces the cleavage of ZIF-8, facilitating the release of At10, which effectively targets bacterial membranes to exert its antibacterial effects. Bacteria treated with At10/CuS@ZIF-8 under light radiation exhibited not only membrane folding and intracellular matrix outflow but also bacterial fracture. This synergistic antibacterial strategy, integrating the unique properties of AMPs, CuS NPs, and pH responsiveness of ZIF-8, holds promising potential for widespread application in the treatment of bacterial infections. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09396411
Volume :
204
Database :
Academic Search Index
Journal :
European Journal of Pharmaceutics & Biopharmaceutics
Publication Type :
Academic Journal
Accession number :
180422845
Full Text :
https://doi.org/10.1016/j.ejpb.2024.114516